1 |
AstraZeneca AB et al v. Mylan Laboratories Limited et al |
1:12-cv-00300 |
D.Del. |
|
|
|
|
2 |
AstraZeneca AB et al v. Mylan Laboratories Limited et al |
1:12-cv-00300 |
D.Del. |
|
|
|
|
3 |
AstraZeneca AB et al v. Mylan Laboratories Limited et al |
1:12-cv-00300 |
D.Del. |
|
|
|
|
4 |
AstraZeneca AB et al v. Mylan Laboratories Limited et al |
1:12-cv-00300 |
D.Del. |
|
|
|
|
5 |
AstraZeneca AB et al v. Mylan Laboratories Limited et al |
1:12-cv-00300 |
D.Del. |
|
|
|
|
6 |
Fresenius Kabi USA, LLC v. Mylan Laboratories Limited et al |
1:14-cv-00205 |
N.D.W.Va. |
|
|
|
|
7 |
AbbVie Inc. v. Mylan Pharmaceuticals Inc. et al |
1:14-cv-01236 |
D.Del. |
|
|
|
|
8 |
Cadence Pharmaceuticals Inc. et al v. Agila Specialties Inc. et al |
1:14-cv-01499 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
9 |
Cadence Pharmaceuticals Inc. et al v. Agila Specialties Inc. et al |
1:14-cv-01499 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
10 |
Cadence Pharmaceuticals Inc. et al v. Agila Specialties Inc. et al |
1:14-cv-01499 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
11 |
OTSUKA PHARMACEUTICAL CO., LTD. v. MYLAN INC. et al |
1:14-cv-04508 |
D.N.J. |
|
|
|
|
12 |
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:15-cv-00145 |
N.D.W.Va. |
|
|
|
|
13 |
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:15-cv-00145 |
N.D.W.Va. |
|
|
|
|
14 |
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:15-cv-00145 |
N.D.W.Va. |
|
|
|
|
15 |
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:15-cv-00145 |
N.D.W.Va. |
|
|
|
|
16 |
ABBVIE INC. et al v. MYLAN PHARMACEUTICALS INC. et al |
1:15-cv-01402 |
N.D.Ill. |
|
|
|
|
17 |
ABBVIE INC. et al v. MYLAN PHARMACEUTICALS INC. et al |
1:15-cv-01402 |
N.D.Ill. |
|
|
|
|
18 |
ABBVIE INC. et al v. MYLAN PHARMACEUTICALS INC. et al |
1:15-cv-01402 |
N.D.Ill. |
|
|
|
|
19 |
ASTRAZENECA PHARMACEUTICALS LP et al v. MYLAN PHARMACEUTICALS INC. et al |
1:15-cv-07009 |
D.N.J. |
|
|
|
|
20 |
ASTRAZENECA PHARMACEUTICALS LP et al v. MYLAN PHARMACEUTICALS INC. et al |
1:15-cv-07009 |
D.N.J. |
|
|
|
|
21 |
ASTRAZENECA PHARMACEUTICALS LP et al v. MYLAN PHARMACEUTICALS INC. et al |
1:15-cv-07009 |
D.N.J. |
|
|
|
|
22 |
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00184 |
N.D.W.Va. |
|
|
|
|
23 |
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00184 |
N.D.W.Va. |
|
|
|
|
24 |
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00184 |
N.D.W.Va. |
|
|
|
|
25 |
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00184 |
N.D.W.Va. |
|
|
|
|
26 |
Merck Sharp & Dohme Corp. v. Fresenius Kabi USA, LLC |
1:18-cv-00196 |
D.Del. |
|
|
|
|
27 |
Merck Sharp & Dohme Corp. v. Fresenius Kabi USA, LLC |
1:18-cv-00196 |
D.Del. |
|
|
|
|
28 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:20-cv-00090 |
N.D.W.Va. |
|
|
|
|
29 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:20-cv-00090 |
N.D.W.Va. |
|
|
|
|
30 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:20-cv-00090 |
N.D.W.Va. |
|
|
|
|
31 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:20-cv-00090 |
N.D.W.Va. |
|
|
|
|
32 |
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. et al |
1:20-md-00445 |
D.Del. |
|
|
|
|
33 |
Warner Chilcott (US), LLC et al v. Mylan Pharmaceuticals, Inc. et al |
2:15-cv-01740 |
E.D.Tex. |
|
|
|
|
34 |
Warner Chilcott (US), LLC et al v. Mylan Pharmaceuticals, Inc. et al |
2:15-cv-01740 |
E.D.Tex. |
|
|
|
|
35 |
Warner Chilcott (US), LLC et al v. Mylan Pharmaceuticals, Inc. et al |
2:15-cv-01740 |
E.D.Tex. |
|
|
|
|
36 |
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARMACEUTICALS, INC. et al |
2:15-cv-08180 |
D.N.J. |
|
|
|
|
37 |
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARMACEUTICALS, INC. et al |
2:15-cv-08180 |
D.N.J. |
|
|
|
|
38 |
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARMACEUTICALS, INC. et al |
2:15-cv-08180 |
D.N.J. |
|
|
|
|
39 |
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARMACEUTICALS, INC. et al |
2:15-cv-08180 |
D.N.J. |
|
|
|
|
40 |
GENZYME CORPORATION et al v. MYLAN LABORATORIES LIMITED et al |
2:16-cv-05828 |
D.N.J. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
41 |
GENZYME CORPORATION et al v. MYLAN LABORATORIES LIMITED et al |
2:16-cv-05828 |
D.N.J. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
42 |
GENZYME CORPORATION et al v. MYLAN LABORATORIES LIMITED et al |
2:16-cv-05828 |
D.N.J. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
43 |
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARAMACEUTICALS, INC. et al |
2:17-cv-06714 |
D.N.J. |
|
|
|
|
44 |
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARAMACEUTICALS, INC. et al |
2:17-cv-06714 |
D.N.J. |
|
|
|
|
45 |
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARAMACEUTICALS, INC. et al |
2:17-cv-06714 |
D.N.J. |
|
|
|
|
46 |
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARAMACEUTICALS, INC. et al |
2:17-cv-06714 |
D.N.J. |
|
|
|
|
47 |
HORIZON PHARMA, INC., ET AL. V. DR. REDDY'S LABORATORIES, INC., ET AL. |
2:17-cv-11635 |
D.N.J. |
|
|
|
|
48 |
HORIZON PHARMA, INC., ET AL. V. DR. REDDY'S LABORATORIES, INC., ET AL. |
2:17-cv-11635 |
D.N.J. |
|
|
|
|
49 |
HORIZON PHARMA, INC. et al v. MYLAN PHARMACEUTICALS INC. et al |
3:15-cv-03327 |
D.N.J. |
|
|
|
|
50 |
HORIZON PHARMA, INC. et al v. MYLAN PHARMACEUTICALS INC. et al |
3:15-cv-03327 |
D.N.J. |
|
|
|
|